AbbVie (BSP:ABBV34) ROE % Adjusted to Book Value : 1.12% (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is AbbVie ROE % Adjusted to Book Value?

AbbVie's ROE % for the quarter that ended in Dec. 2023 was 29.16%. AbbVie's PB Ratio for the quarter that ended in Dec. 2023 was 25.97. AbbVie's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 1.12%.

AbbVie ROE % Adjusted to Book Value Historical Data

The historical data trend for AbbVie's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AbbVie ROE % Adjusted to Book Value Chart

AbbVie Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

Negative Equity

9.77

5.52

4.20

1.30

AbbVie Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															3.58	0.31	3.26	2.59	1.12

Competitive Comparison of AbbVie's ROE % Adjusted to Book Value

For the Drug Manufacturers - General subindustry, AbbVie's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AbbVie's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AbbVie's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where AbbVie's ROE % Adjusted to Book Value falls into.

AbbVie ROE % Adjusted to Book Value Calculation

AbbVie's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	33.73%	/	25.97
	=	1.30%

AbbVie's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	29.16%	/	25.97
	=	1.12%

AbbVie ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of AbbVie's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

AbbVie (BSP:ABBV34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AbbVie Inc (BSP:ABBV34) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

ABBV:USA ABBV:Mexico 1ABBV:Italy 4ABd:UK 0QCV:UK 4AB:Germany ABBV:Canada ABBV:Austria

Address

1 North Waukegan Road, North Chicago, IL, USA, 60064-6400

Website

http://www.abbvieinvestor.com

AbbVie is a pharmaceutical firm with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

AbbVie (BSP:ABBV34) Headlines

No Headlines